106 related articles for article (PubMed ID: 1412158)
21. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
[TBL] [Abstract][Full Text] [Related]
22. Opposing effects of low and high molecular weight kininogens on cell adhesion.
Asakura S; Yang W; Sottile J; Zhang Q; Jin Y; Ohkubo I; Sasaki M; Matsuda M; Hirata H; Mosher DF
J Biochem; 1998 Sep; 124(3):473-84. PubMed ID: 9722655
[TBL] [Abstract][Full Text] [Related]
23. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
Zini JM; Schmaier AH; Cines DB
Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
[TBL] [Abstract][Full Text] [Related]
24. Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA).
Scott CF; Shull B; Müller-Esterl W; Colman RW
Thromb Haemost; 1997 Jan; 77(1):109-18. PubMed ID: 9031459
[TBL] [Abstract][Full Text] [Related]
25. The pharmacokinetics of the kininogens.
Schmaier AH; Wahl R; Fisher SJ; Brenner D
Thromb Res; 1998 Dec; 92(6):293-7. PubMed ID: 9870897
[TBL] [Abstract][Full Text] [Related]
26. Commercial immunodepleted deficient plasmas contain cleaved high molecular weight kininogen (HK).
Mannhalter C; Lang H
Thromb Haemost; 1988 Dec; 60(3):447-52. PubMed ID: 3238647
[TBL] [Abstract][Full Text] [Related]
27. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.
Gustafson EJ; Lukasiewicz H; Wachtfogel YT; Norton KJ; Schmaier AH; Niewiarowski S; Colman RW
J Cell Biol; 1989 Jul; 109(1):377-87. PubMed ID: 2526132
[TBL] [Abstract][Full Text] [Related]
28. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains.
Kunapuli SP; DeLa Cadena RA; Colman RW
J Biol Chem; 1993 Feb; 268(4):2486-92. PubMed ID: 8428925
[TBL] [Abstract][Full Text] [Related]
29. High molecular weight kininogen is an inhibitor of platelet calpain.
Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
[TBL] [Abstract][Full Text] [Related]
30. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
Hock J; Vogel R; Linke RP; Müller-Esterl W
J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
[TBL] [Abstract][Full Text] [Related]
31. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies.
Berrettini M; Lämmle B; White T; Heeb MJ; Schwarz HP; Zuraw B; Curd J; Griffin JH
Blood; 1986 Aug; 68(2):455-62. PubMed ID: 3730610
[TBL] [Abstract][Full Text] [Related]
32. Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils.
Figueroa CD; Henderson LM; Kaufmann J; De La Cadena RA; Colman RW; Müller-Esterl W; Bhoola KD
Blood; 1992 Feb; 79(3):754-9. PubMed ID: 1732013
[TBL] [Abstract][Full Text] [Related]
33. Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties.
Kaufmann J; Haasemann M; Modrow S; Müller-Esterl W
J Biol Chem; 1993 Apr; 268(12):9079-91. PubMed ID: 7682558
[TBL] [Abstract][Full Text] [Related]
34. Interaction of human calpains I and II with high molecular weight and low molecular weight kininogens and their heavy chain: mechanism of interaction and the role of divalent cations.
Ishiguro H; Higashiyama S; Namikawa C; Kunimatsu M; Takano E; Tanaka K; Ohkubo I; Murachi T; Sasaki M
Biochemistry; 1987 May; 26(10):2863-70. PubMed ID: 3038169
[TBL] [Abstract][Full Text] [Related]
35. Identification of an endothelial cell binding site on kininogen domain D3.
Herwald H; Hasan AA; Godovac-Zimmermann J; Schmaier AH; Müller-Esterl W
J Biol Chem; 1995 Jun; 270(24):14634-42. PubMed ID: 7540175
[TBL] [Abstract][Full Text] [Related]
36. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains.
Reddigari SR; Kuna P; Miragliotta G; Shibayama Y; Nishikawa K; Kaplan AP
Blood; 1993 Mar; 81(5):1306-11. PubMed ID: 8443392
[TBL] [Abstract][Full Text] [Related]
37. High-molecular weight kininogen. A secreted platelet protein.
Schmaier AH; Zuckerberg A; Silverman C; Kuchibhotla J; Tuszynski GP; Colman RW
J Clin Invest; 1983 May; 71(5):1477-89. PubMed ID: 6406551
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets.
Kerbiriou-Nabias DM; Garcia FO; Larrieu MJ
Br J Haematol; 1984 Feb; 56(2):273-86. PubMed ID: 6691922
[TBL] [Abstract][Full Text] [Related]
39. High molecular weight kininogen binds to unstimulated platelets.
Gustafson EJ; Schutsky D; Knight LC; Schmaier AH
J Clin Invest; 1986 Jul; 78(1):310-8. PubMed ID: 3722381
[TBL] [Abstract][Full Text] [Related]
40. Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions.
Vogel R; Assfalg-Machleidt I; Esterl A; Machleidt W; Müller-Esterl W
J Biol Chem; 1988 Sep; 263(25):12661-8. PubMed ID: 3045123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
